tiprankstipranks
Circassia Pharmaceuticals PLC (GB:NIOX)
LSE:NIOX
UK Market
NIOX
Circassia Pharmaceuticals
RESEARCH TOOLSreports
Want to see GB:NIOX full AI Analyst Report?

Circassia Pharmaceuticals (NIOX) Ratios

14 Followers

Circassia Pharmaceuticals Ratios

GB:NIOX's free cash flow for Q4 2025 was £0.60. For the 2025 fiscal year, GB:NIOX's free cash flow was decreased by £ and operating cash flow was £0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.81 3.81 2.60 4.65 3.41
Quick Ratio
 3.20 3.20 2.11 3.99 2.97
Cash Ratio
 2.46 2.46 1.35 2.76 2.11
Solvency Ratio
 1.06 0.81 0.89 1.96 1.25
Operating Cash Flow Ratio
 1.95 1.95 2.12 1.61 0.73
Short-Term Operating Cash Flow Coverage
 31.60 31.60 24.57 19.33 11.17
Net Current Asset Value
£ 22.30M£ 22.30M£ 12.20M£ 25.80M£ 14.80M
Leverage Ratios
Debt-to-Assets Ratio
 0.01 0.01 0.02 0.01 0.01
Debt-to-Equity Ratio
 0.01 0.01 0.03 0.01 0.01
Debt-to-Capital Ratio
 0.01 0.01 0.02 0.01 0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.03 1.03 1.15 1.09 1.20
Debt Service Coverage Ratio
 12.57 9.29 8.67 17.50 26.86
Interest Coverage Ratio
 53.50 53.50 38.50 23.00 18.00
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 -1.45 -1.77 -0.77 -2.19 -1.21
Profitability Margins
Gross Profit Margin
60.78%60.78%72.25%72.01%70.93%
EBIT Margin
22.38%21.97%19.14%11.41%33.87%
EBITDA Margin
26.69%21.97%29.19%23.37%48.56%
Operating Profit Margin
21.97%21.97%18.42%12.50%5.75%
Pretax Profit Margin
23.00%23.00%18.66%11.14%33.55%
Net Profit Margin
14.37%14.37%8.85%29.08%51.44%
Continuous Operations Profit Margin
14.37%14.37%8.13%25.82%45.05%
Net Income Per EBT
62.50%62.50%47.44%260.98%153.33%
EBT Per EBIT
104.67%104.67%101.30%89.13%583.33%
Return on Assets (ROA)
9.19%9.19%5.41%11.69%16.35%
Return on Equity (ROE)
10.14%9.50%6.22%12.77%19.66%
Return on Capital Employed (ROCE)
15.71%15.71%12.77%5.46%2.02%
Return on Invested Capital (ROIC)
9.75%9.75%5.44%5.38%1.99%
Return on Tangible Assets
14.71%14.71%9.11%18.23%26.22%
Earnings Yield
2.38%2.55%1.40%3.80%10.52%
Efficiency Ratios
Receivables Turnover
 8.12 8.12 6.74 4.18 3.96
Payables Turnover
 2.51 2.51 7.25 9.36 18.20
Inventory Turnover
 3.82 3.82 2.90 2.15 2.22
Fixed Asset Turnover
 40.58 40.58 24.59 26.29 28.45
Asset Turnover
 0.64 0.64 0.61 0.40 0.32
Working Capital Turnover Ratio
 2.48 2.72 2.13 1.52 2.01
Cash Conversion Cycle
 -4.72 -4.72 129.66 218.40 236.52
Days of Sales Outstanding
 44.97 44.97 54.14 87.28 92.12
Days of Inventory Outstanding
 95.55 95.55 125.86 170.10 164.45
Days of Payables Outstanding
 145.24 145.24 50.34 38.98 20.05
Operating Cycle
 140.52 140.52 180.00 257.38 256.58
Cash Flow Ratios
Operating Cash Flow Per Share
 0.04 0.04 0.04 0.03 0.02
Free Cash Flow Per Share
 0.04 0.04 0.04 0.03 0.02
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.99 0.99 0.94 0.97 0.99
Dividend Paid and CapEx Coverage Ratio
 3.04 3.04 3.31 1.07 67.00
Capital Expenditure Coverage Ratio
 79.00 79.00 17.20 38.67 67.00
Operating Cash Flow Coverage Ratio
 15.80 15.80 11.47 10.55 6.70
Operating Cash Flow to Sales Ratio
 0.32 0.32 0.41 0.32 0.21
Free Cash Flow Yield
5.33%5.67%6.15%4.01%4.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 41.10 39.29 71.21 26.31 9.50
Price-to-Sales (P/S) Ratio
 5.87 5.65 6.30 7.65 4.89
Price-to-Book (P/B) Ratio
 3.90 3.73 4.43 3.36 1.87
Price-to-Free Cash Flow (P/FCF) Ratio
 18.33 17.63 16.26 24.91 23.18
Price-to-Operating Cash Flow Ratio
 18.21 17.41 15.32 24.27 22.84
Price-to-Earnings Growth (PEG) Ratio
 0.36 0.43 -1.09 -0.78 0.03
Price-to-Fair Value
 3.90 3.73 4.43 3.36 1.87
Enterprise Value Multiple
 20.54 23.94 20.83 30.55 8.86
Enterprise Value
 273.71M 256.11M 254.07M 262.74M 134.61M
EV to EBITDA
 21.05 23.94 20.83 30.55 8.86
EV to Sales
 5.62 5.26 6.08 7.14 4.30
EV to Free Cash Flow
 17.55 16.42 15.68 23.25 20.40
EV to Operating Cash Flow
 17.32 16.21 14.77 22.65 20.09
Tangible Book Value Per Share
 0.09 0.09 0.08 0.12 0.11
Shareholders’ Equity Per Share
 0.17 0.18 0.14 0.20 0.20
Tax and Other Ratios
Effective Tax Rate
 0.38 0.38 0.56 -1.32 -0.34
Revenue Per Share
 0.12 0.12 0.10 0.09 0.07
Net Income Per Share
 0.02 0.02 <0.01 0.03 0.04
Tax Burden
 0.63 0.63 0.47 2.61 1.53
Interest Burden
 1.03 1.05 0.97 0.98 0.99
Research & Development to Revenue
 0.02 0.00 0.06 0.06 0.10
SG&A to Revenue
 0.33 0.33 0.48 0.23 0.24
Stock-Based Compensation to Revenue
 0.00 0.00 0.05 0.07 0.03
Income Quality
 2.26 2.26 2.12 2.19 0.54
Currency in GBP